Some individuals may reach their goals on a very low dose, while others may require the full therapeutic amount
You can read the full article atYou can read the full article at Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes in SUSTAIN China: A 30-week, double-blind, phase 3a, randomized trial Due to increased obesity and inactivity rates, type 2 diabetes (T2D) is a complex, multifaceted disease with a rising prevalence rate
Severe Allergic Reactions (Rare) Though uncommon, some people may experience serious allergic reactions to PanOxyl
Clinical study of Jinshuibao capsule combined with sulodide in the treatment of early diabetes nephropathy
Many clinical trials have demonstrated that GLP-1 receptor agonists reduce urinary albumin levels in patients with diabetes
Some are concerned about the potential side effects and risks related to this practice for certain indications